The impact of Pim-mediated phosphorylation of Notch on tumor progression is demonstrated by our in vivo data from the CAM assays, where Pim and Notch synergistically enhance tumorigenic growth of both breast and prostate cancer cells. The gene discussed is PIM1; the disease is prostate carcinoma.